Chinese biotech company Beijing InnoCare Pharma Tech Co. (InnoCare) has secured a US$160 million new round of financing led by the country’s private equity investment management firm Loyal Valley Capital, according to a statement released on InnoCare’s website on Friday.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
